10x Genomics’ (TXG) “Sell (E+)” Rating Reaffirmed at Weiss Ratings
Weiss Ratings reaffirmed their sell (e+) rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report released on Tuesday morning,Weiss Ratings reports. A number of other research analysts have also weighed in on TXG. Barclays reduced their target price on 10x Genomics from $19.00 to $18.00 and set an “overweight” rating for […]
Weiss Ratings reaffirmed their sell (e+) rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report released on Tuesday morning,Weiss Ratings reports. A number of other research analysts have also weighed in on TXG. Barclays reduced their target price on 10x Genomics from $19.00 to $18.00 and set an “overweight” rating for […]